Share Name Share Symbol Market Type Share ISIN Share Description
Oxford Pharm Gp LSE:OXP London Ordinary Share GB00B3LXPB43 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.05p +1.71% 2.975p 2.85p 3.10p 3.00p 2.925p 2.925p 287,785.00 14:34:26
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.8 -1.9 -0.1 - 35.87

Oxford Pharm Gp Share Discussion Threads

Showing 776 to 800 of 800 messages
Chat Pages: 32  31  30  29  28  27  26  25  24  23  22  21  Older
DateSubjectAuthorDiscuss
21/3/2017
11:56
Mmmm.... a bit of a false dawn, today - the rise appears to have been soon sold into, even though still standing higher than previouly. f
fillipe
21/3/2017
08:47
OXP has moved up quite a % bit in the last week. Looks quite strongish to me, with a 100k lot taken at 3.03p just this minute. f
fillipe
14/3/2017
19:50
There were some large trade at 3p and above. I feel that there is no smoke without fire and they will be pulled back up. I unfortunately took a profit at 2.18 and missed on the rise. Anyone any have any sensible entry point views?
carbon man
01/3/2017
15:59
Dips being bought, looking for another run to 3.5p pre news. Good news should see this back to 10p placing price. It can happen. Just tuck them away and trade something else IMO.
nick rubens
23/2/2017
09:44
PU, many thanks for the snippet on surface transforms. I will respond in more detail later, I'm currently on a plane (to Vegas) waiting to take off, hence the brevity.
timbo003
23/2/2017
09:32
timbo003: Thanks. Re SCE - I think you are a holder - Had a chat with DB recently and also looked at web cast - Time lines extended but will continue to hold risk/reward (imo) still tilted in favour of reward. (If of any use to you) Usual cautions apply
pugugly
23/2/2017
09:28
PG No, I remain very sceptical
timbo003
23/2/2017
09:03
I'm not sure they've given up on the GI part. "This study is to help development of a new version of Ibuprofen, called Ibuprofen-LDH. Ibuprofen-LDH will be used as a treatment for muscular pains, headache, fever etc. This new version of ibuprofen is expected to produce fewer stomach/intestine related side effects when compared to many existing marketed formulations of Ibuprofen." HTTPS://www.clinicaltrials.gov/ct2/show/NCT02974361?term=NCT02974361&rank=1 I sure hope they haven't as I see the GI part as the most interesting.
greedfear
23/2/2017
08:53
timbo003. Can you translate please into consumer speak and also have you changed your mind about the technology (your post 730 above) so as to make this worth looking at again.
pugugly
23/2/2017
08:45
Good to see that they have given up trying to obtain GI safe claims for an OTC formula, as this was always a non-starter as far as I was concerned. I doubt if they will get improved taste masking with faster acting, but they should be able to achieve taste masking without the speed claims.
timbo003
23/2/2017
08:28
Very good news. Having trust in an increasing share price
greedfear
23/2/2017
07:57
Update...we need advice from the experts on this.
barnetpeter
21/2/2017
14:02
hmmm..has been a bit quiet lately
113mike
21/2/2017
13:54
another million buy gone through. Serious cash
barnetpeter
15/2/2017
00:33
Quite happy with that.
meanwhile back at the ranch
10/2/2017
13:58
They are at it Dropped the share price over lunch to gather shares for the one million buyer
risk1
09/2/2017
10:21
Quite some drop as well Was the drop justified?
risk1
09/2/2017
10:14
It's been some rally! The news needs to be very good I guess to justify this re rating but the 22 million in cash 💰 always puts a limit on the downside. I wonder if some company is sniffing around?
barnetpeter
09/2/2017
09:57
News can land anytime and if it's good then a rerate will ensue. "Dosing for all three study parts is due to complete by the end of the second quarter of 2017, with first readouts are also expected in the second quarter. Oxford Pharmascience also said it expects responses from the US Food and Drug Administration over the regulatory pathway for OXPzero ibuprofen in the first quarter of 2017."
nick rubens
08/2/2017
16:02
..and so it came to pass..
donald trumpton
08/2/2017
09:38
This is just how OXP moves don't you know.
donald trumpton
08/2/2017
09:27
very nice. Vertical take off. FOLLOW HASHTAG TRICKSTER 1.8M FOLLOWERS
trickster1
08/2/2017
09:25
Like yesterday any sells get soaked up and forward it goes again
burbelly
08/2/2017
09:24
Feels like a reasonable 6p on it's way and especially if an update includes a customer win. Seeing Woodford funding itat 10p gives me confidence not to risk trading out of it. Could be one of those where buying on the way up on any dips makes sense this time. I may have to pluck up the courage to do that myself.
nick rubens
08/2/2017
09:13
Flying again. Doubled for me. Taken my stake out now in full and will wait for news. Those who were selling at 1.6 and below cash a short while ago must be fed up
barnetpeter
Chat Pages: 32  31  30  29  28  27  26  25  24  23  22  21  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:30 V: D:20170325 23:40:51